|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D25.2 |
Subserosal leiomyoma of uterus
Diagnosis Valid for Female Patient Only
|
D252 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 23.55%
|
29.13%
|
20.94%
|
10.96%
|
6.39%
|
2.88%
|
1.85%
|
1.11%
|
0.90%
|
0.52%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D25.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
76830
|
TRANSVAGINAL US NON-OB |
848
|
848
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
747
|
1,934
|
|
76856
|
US EXAM PELVIC COMPLETE |
669
|
669
|
|
J2405
|
ONDANSETRON HCL INJECTION |
385
|
1,823
|
|
J3010
|
FENTANYL CITRATE INJECTION |
372
|
795
|
|
J1885
|
KETOROLAC TROMETHAMINE INJ |
334
|
679
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
314
|
9,274
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
311
|
315
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
286
|
2,185
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
284
|
305
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
281
|
2,058
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
258
|
1,123
|
|
J7120
|
RINGERS LACTATE INFUSION |
257
|
448
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
240
|
508
|
|
86900
|
BLOOD TYPING SEROLOGIC ABO |
234
|
237
|
|
J1170
|
HYDROMORPHONE INJECTION |
231
|
431
|
|
86901
|
BLOOD TYPING SEROLOGIC RH(D) |
231
|
235
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
221
|
222
|
|
86850
|
RBC ANTIBODY SCREEN |
209
|
210
|
|
58571
|
TLH W/T/O 250 G OR LESS |
196
|
196
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D25.2 related to the following DRG Codes:
742-743
760-761
|
